- Distinct mode of action of a highly stable, engineered phage lysin killing Gram-negative bacteria(2023)
Auteurs: Hans Gerstmans, Lisa Duyvejonck, Roberto Vazquez Fernandez, Ines Staes, Jimmy Borloo, Karim Abdelkader, Jeroen Leroy, Emma Cremelie, Diana Gutierrez Fernandez, Héctor Tamés-Caunedo, et al.
- The specific capsule depolymerase of phage PMK34 sensitizes Acinetobacter baumannii to serum killing(2022)
Auteurs: Karim Abdelkader, Diana Gutierrez Fernandez, Agnieszka Łątka, Dimitri Boeckaerts, Zuzanna Drulis-Kawa, Bjorn Criel, Hans Gerstmans, Amal Safaan, Ahmed S. Khairalla, Yasser Gaber, et al.
- Engineering a lysin with intrinsic antibacterial activity (LysMK34) by cecropin a fusion enhances its antibacterial properties against acinetobacter baumannii(2022)
Auteurs: Karim Abdelkader, Diana Gutierrez Fernandez, Héctor Tamés-Caunedo, Patricia Ruas-Madiedo, Amal Safaan, Ahmed S. Khairalla, Yasser Gaber, Tarek Dishisha, Yves Briers
- Lysin LysMK34 of Acinetobacter baumannii bacteriophage PMK34 has a turgor pressure-dependent intrinsic antibacterial activity and reverts colistin resistance(2020)
Auteurs: Karim Abdelkader, Diana Gutierrez Fernandez, Dennis Grimon, Patricia Ruas-Madiedo, Cédric Lood, Rob Lavigne, Amal Safaan, Ahmed S. Khairalla, Yasser Gaber, Tarek Dishisha, et al.
- The preclinical and clinical progress of bacteriophages and their lytic enzymes : the parts are easier than the whole(2019)
Auteurs: Karim Abdelkader, Hans Gerstmans, Amal Saafan, Tarek Dishisha, Yves Briers